Mass General Brigham Study Finds That Patients With Glioblastoma Who Received Gabapentin Lived Longer
May 16, 2025
May 16, 2025
BOSTON, Massachusetts, May 16 -- Mass General Brigham issued the following news release:
* * *
Mass General Brigham Study Finds That Patients with Glioblastoma Who Received Gabapentin Lived Longer
A new study by investigators from Mass General Brigham suggests that gabapentin, a relatively common anti-seizure/pain medication, is linked to improved survival in patients with glioblastoma (GBM)--the most common and deadly form of brain cancer in adults. The fi . . .
* * *
Mass General Brigham Study Finds That Patients with Glioblastoma Who Received Gabapentin Lived Longer
A new study by investigators from Mass General Brigham suggests that gabapentin, a relatively common anti-seizure/pain medication, is linked to improved survival in patients with glioblastoma (GBM)--the most common and deadly form of brain cancer in adults. The fi . . .